SARS-CoV-2 Spike RBD Nanobody, FITC conjugated, Camelus, Monoclonal

Artikelnummer: CSB-RA33245C2GMY-100
Artikelname: SARS-CoV-2 Spike RBD Nanobody, FITC conjugated, Camelus, Monoclonal
Artikelnummer: CSB-RA33245C2GMY-100
Hersteller Artikelnummer: CSB-RA33245C2GMY
Alternativnummer: CSB-RA33245C2GMY-100
Hersteller: Cusabio
Wirt: Camelus
Kategorie: Antikörper
Spezies Reaktivität: Virus
Konjugation: FITC
Alternative Synonym: Anti-coronavirus spike Antibody, Anti-cov spike Antibody, Anti-ncov RBD Antibody, Anti-ncov S1 Antibody,Anti-ncov spike Antibody, Anti-novel coronavirus RBD Antibody, Anti-novel coronavirus S1 Antibody, Anti-novel coronavirus spike Antibody, Anti-RBD Antibody, Anti-S1 Antibody, Anti-Spike RBD Antibody, E2 Antibody, E2 glycoprotein Antibody, Human coronavirus spike glycoprotein Antibody, S Antibody, SARS-CoV-2 S1 RBD Antibody, S glycoprotein Antibody, Spike glycoprotein Antibody, sars-cov-2
Klonalität: Monoclonal
UniProt: P0DTC2
Puffer: Preservative: 0.03% Proclin 300<br />Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Reinheit: Affinity-chromatography
Formulierung: Liquid
Target-Kategorie: S
Antibody Type: Recombinant Antibody